REGN NASDAQ · Healthcare · FY 2025-12-31

REGENERON PHARMACEUTICALS, INC.

0.0205.9411.8617.7823.6ABVfair 283.77buy ≤ 212.83EPVfair 573.09buy ≤ 315.20EBVfair 525.30buy ≤ 341.45DBVnot valid for this companyprice 762.63 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Franchise
Confidence
●●● High · 3/4

Price
762.63 USD
Market cap
80.62B USD
P / B
2.58
P / E
18.39
EPS
41.480
DPS / yield
3.640 (0.5%)
NAV / share
283.77
Graham number
525.30
Z'' score
9.49
Piotroski F
5 / 9
Beneish M
-2.53
ROIC vs WACC
14.7% vs 5.9%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.